Skip to main content
Year archive

Heidelberg Pharma AG — 2014 filings

All 29 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2014, sourced directly from the official regulator.

29 Filings
2014 Period
2014 filings (29)
Filing Released Lang
WILEX AG publishes 9-month Financial Report 2014
Earnings Release 9M 2014
2014-10-15 English
Q3 Report 2013/2014
Interim / Quarterly Report H2 2014
2014-10-15 German
WILEX AG: WILEX subsidiary Heidelberg Pharma extends research collaboration with Roche
M&A Activity
2014-10-14 English
WILEX AG: WILEX subsidiary Heidelberg Pharma extends research collaboration with Roche
M&A Activity
2014-10-14 English
WILEX AG: UCB waives repayment of shareholder loan to WILEX
Capital/Financing Update
2014-09-18 English
WILEX AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-07-31 English
WILEX AG publishes Half-yearly Financial Report 2014
Earnings Release H1 2014
2014-07-15 English
WILEX AG successfully completes capital reduction
Share Issue/Capital Change
2014-07-15 English
Q2 Report 2013/2014
Interim / Quarterly Report H1 2014
2014-07-15 German
Jahresfinanzbericht 2012/2013
Annual Report FY 2013
2014-07-02 German
WILEX AG: WILEX and RedHill Biopharma enter into an exclusive license agreement for MESUPRON(R)
M&A Activity
2014-06-30 English
WILEX AG: WILEX and RedHill Biopharma enter into an exclusive license agreement for MESUPRON(R)
Regulatory Filings
2014-06-30 English
WILEX AG: WILEX returns rights from collaboration in oncology to UCB and UCB waives repayment of the shareholder loan
Regulatory Filings
2014-05-21 English
WILEX AG: WILEX and IBA terminate marketing partnership - Global rights to REDECTANE(R) diagnostic agent revert to WILEX
M&A Activity
2014-04-30 English
Wilex AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.05.2014 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2014-04-14 German
WILEX AG publishes 3-month Financial Report 2014
Earnings Release Q1 2014
2014-04-14 English
Q1 Report 2013/2014
Interim / Quarterly Report Q1 2014
2014-04-14 German
WILEX AG plans reduction of share capital
Share Issue/Capital Change
2014-04-10 English
WILEX AG: WILEX announces financial figures for the 2013 financial year and reportson course of business
Earnings Release FY 2013
2014-03-31 English
Annual Financial Statements 2012/2013
Annual Report FY 2013
2014-03-31 English
WILEX AG: WILEX enters into licensing and development partnership for MESUPRON(R) in China with Link Health Group
M&A Activity
2014-03-28 English
WILEX AG: WILEX enters into licensing and development partnership for MESUPRON(R) in China with Link Health Group
M&A Activity
2014-03-28 English
Report Publication Announcement 2014
Report Publication Announcement
2014-03-28 English
WILEX AG: WILEX will publish the financial results and the Annual Report 2013 on March 31, 2014
Report Publication Announcement
2014-03-25 English
WILEX AG: Professor Olaf G. Wilhelm leaves the Executive Management Board on 31 March 2014, Dr Jan Schmidt-Brand will lead the Company
Board/Management Information
2014-02-24 English
WILEX AG: Professor Olaf G. Wilhelm leaves the Executive Management Board on 31 March 2014, Dr Jan Schmidt-Brand will lead the Company
Board/Management Information
2014-02-24 English
WILEX AG plans extensive cost-cutting measures
Management Reports
2014-01-29 English
WILEX AG plans extensive cost-cutting measures
Capital/Financing Update
2014-01-29 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-01-02 English